by webdevx | Sep 21, 2022 | LS
By: Laura Fuentes (Source: EMA) A biosimilar medicine is a biological medicine that is very similar to an authorized biological medicine and works in the same way. Biosimilar products facilitate patient access to treatment by making biologic medicines more affordable...
by webdevx | Sep 21, 2022 | Blog legal LS
Por Laura Fuentes (Fuente: EMA) Un medicamento biosimilar es un medicamento biológico qué es muy similar a un medicamento biológico y autorizado, y que funciona del mismo modo. Los productos biosimilares facilitan el acceso de los pacientes a tratamientos pues hacen...
by webdevx | Sep 20, 2022 | News Alerts
By: Lic. Alfredo Roque Castillo On September 2, 2022, Resolution No. 467-2022 (COMEICO-C) was published in “La Gaceta Diario Oficial”, in which it is resolved to replace the Central American Technical Regulation RTCA 71.03.36:07 Cosmetic Products, which appears as...
by webdevx | Sep 20, 2022 | Alerta Informativa LS
Por: Alfredo Roque El día 2 de septiembre de 2022, se publicó en La Gaceta Diario Oficial la Resolución No. 467-2022 (COMEICO-C), en la cual se resuelve sustituir el Reglamento Técnico Centroamericano RTCA 71.03.36:07 Productos Cosméticos, la cual aparece como anexo 3...
by webdevx | Sep 19, 2022 | Releases
By: Laura Portillo, Olga Torres. On September nineteenth of this year, the National Directorate of Medicines gives a new term of twenty working days to regularize the pending payments of the Annual Registration Fees, commercialization and renewal of the sanitary...